|
1818F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management |
Malik V, Johnston C, Donohoe C, Claxton Z, Lucey J, Ravi N, Reynolds JV |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Malik V, Johnston C, Donohoe C, Claxton Z, Lucey J, Ravi N, Reynolds JV. 1818F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management. Clinical Nuclear Medicine 2012; 37(12): 1152-1158 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Aged, 80 and over; Decision Making; Disease-Free Survival; Esophageal Neoplasms /complications /pathology /radionuclide imaging /therapy; False Negative Reactions; Fluorodeoxyglucose F18 /diagnostic use; Humans; Incidence; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Multiple Primary /complications /radionuclide imaging; Positron-Emission Tomography /economics; Tomography, X-Ray Computed AccessionNumber 22013000191 Date bibliographic record published 20/02/2013 |
|
|
|